RELATIONSHIP OF OSTEOPROTEGERIN LEVEL AND CHRONIC KIDNEY DISEASE-METABOLIC BONE DISEASE (CKD-MBD)

被引：0
|
作者：
Harb, Lamyaa [1 ]
机构：
[1] Al Azhar Univ, Cairo, Egypt
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2013年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：467 / 468
页数：2
相关论文
共 50 条
  • [41] Effect of ovariectomy on the progression of chronic kidney disease-mineral bone disorder (CKD-MBD) in female Cy/+ rats
    Colby J. Vorland
    Pamela J. Lachcik
    Elizabeth A. Swallow
    Corinne E. Metzger
    Matthew R. Allen
    Neal X. Chen
    Sharon M. Moe
    Kathleen M. Hill Gallant
    Scientific Reports, 9
  • [42] The French clinician's guide to the Kidney disease: Improving global outcomes (KDIGO) for chronic kidney disease-mineral and bone disorders (CKD-MBD)
    Jean, G.
    Chazot, C.
    NEPHROLOGIE & THERAPEUTIQUE, 2010, 6 (03): : 151 - 157
  • [43] Phosphate binders, vitamin D and calcimimetics in the management of chronic kidney disease–mineral bone disorders (CKD-MBD) in children
    Katherine Wesseling-Perry
    Isidro B. Salusky
    Pediatric Nephrology, 2013, 28 : 617 - 625
  • [44] Real-world usage of Chronic Kidney Disease - Mineral Bone Disorder (CKD-MBD) biomarkers in nephrology practices
    Fusaro, Maria
    Barbuto, Simona
    Gallieni, Maurizio
    Cossettini, Althea
    Sarto, Giulia Vanessa Re
    Cosmai, Laura
    Cianciolo, Giuseppe
    La Manna, Gaetano
    Nickolas, Thomas
    Ferrari, Serge
    Bover, Jordi
    Haarhaus, Mathias
    Marino, Carmela
    Mereu, Maria Cristina
    Ravera, Maura
    Plebani, Mario
    Zaninotto, Martina
    Cozzolino, Mario
    Bianchi, Stefano
    Messa, Piergiorgio
    Gregorini, Mariacristina
    Gasperoni, Lorenzo
    Agosto, Caterina
    Aghi, Andrea
    Tripepi, Giovanni
    CLINICAL KIDNEY JOURNAL, 2024, 17 (01)
  • [45] Development and Evaluation of the Psychometric Properties of the CKD-MBD Knowledge and Behavior (CKD-MBD-KB) Questionnaire for Patients With Chronic Kidney Disease
    Shi, Yue-xian
    Si, Wei
    Liu, Jun-duo
    Gao, Min
    Wang, Si-yuan
    Cheng, Mei
    Zhao, Yue
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2016, 51 (03) : 557 - +
  • [46] Pharmaceutical therapy of bone metabolism disorders in chronic kidney disease mineral bone disorder (CKD-MBD) with special respect to antiresorptive substances
    Lehmann, G.
    Wolf, G.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2014, 73 (04): : 329 - +
  • [47] Etelcalcetide Utilization, Dosing Titration, and Chronic Kidney Disease-Mineral and Bone Disease (CKD-MBD) Marker Responses in US Hemodialysis Patients
    Karaboyas, Angelo
    Muenz, Daniel
    Fuller, Douglas S.
    Desai, Pooja
    Lin, Tzu-Chieh
    Robinson, Bruce M.
    Rossetti, Sandro
    Pisoni, Ronald L.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2022, 79 (03) : 362 - 373
  • [48] Feasibility of Quantitative value from bone scintigraphy for the evaluation of bone status in Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD)
    Park, Kyung Hee
    Kim, Hyae Jin
    Kim, Eunsoo
    Hong, Jeong-Min
    Kim, Eun-Jung
    Kim, Keunyoung
    Kim, Seong-Jang
    Song, Sang Heon
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [49] Medikamentöse Therapie von Knochenstoffwechselstörungen bei CKD-MBD („chronic kidney disease – mineral bone disorder“) unter besonderer Berücksichtigung antiresorptiver WirkstoffePharmaceutical therapy of bone metabolism disorders in chronic kidney disease mineral bone disorder (CKD-MBD) with special respect to antiresorptive substances
    G. Lehmann
    G. Wolf
    Zeitschrift für Rheumatologie, 2014, 73 (4) : 329 - 334
  • [50] Evaluating extended-release calcifediol as a treatment option for chronic kidney disease-mineral and bone disorder (CKD-MBD)
    Cozzolino, Mario
    Ketteler, Markus
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (17) : 2081 - 2093
12345